| Literature DB >> 32278875 |
Amanda Ricciuto1, Philip M Sherman2, Ronald M Laxer3.
Abstract
The gut microbiota is integral to human health, including maintaining the delicate balance between tolerance and protection against potentially harmful pathogens. A growing body of evidence implicates the intestinal microbiome in immune-mediated inflammatory disorders; these data span the spectrum from genetic and environmental disease risk factors, to animal studies (particularly germ-free and gnotobiotic models) and human studies, including evidence of dysbiosis in diseased individuals compared to healthy populations. In this review, we summarize both animal and human data supporting a link between the gut microbiota and inflammatory bowel diseases (IBD) and systemic inflammatory arthritis, as models for chronic inflammatory disorders, while offering a pediatric focus (pediatric IBD and juvenile idiopathic arthritis). We discuss relevant mechanisms related to the crosstalk between the gut microbiota and the innate and adaptive immune system. We close with a brief discussion of emerging microbe-altering interventions, including fecal microbial transplantation and its immunologic effects.Entities:
Keywords: Dysbiosis; Fecal microbial transplantation; Inflammatory bowel disease; Juvenile idiopathic arthritis; Microbiota
Mesh:
Year: 2020 PMID: 32278875 DOI: 10.1016/j.clim.2020.108415
Source DB: PubMed Journal: Clin Immunol ISSN: 1521-6616 Impact factor: 3.969